CD177 and cervical cancer: The JAK/STAT signaling pathway is involved in cell surface receptor-mediated signal transduction that accounts for diverse responses to extracellular signaling molecules and is implicated in initiation, progression, metastasis, and resistance to treatment of cervical cancer.